Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Prospective, Randomized, Open-label Study Evaluating the Viral Kinetics and Pharmacokinetics of Pegasys® Plus Copegus® and PEG-Intron® Plus Rebetol® in Interferon-naïve Patients With Chronic Hepatitis C.
Brief Summary: This study will examine the viral kinetics and pharmacokinetics of Pegasys plus ribavirin and PEG-Intron plus ribavirin in interferon-naive patients with CHC. The anticipated time on study treatment is 3-12 months, and the target sample size is 100-500 individuals.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Pegylated interferon alpha 2a, Drug: Ribavirin | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Pegylated interferon alpha 2 b plus ribavirin | Intervention Type: DRUG; Name: Pegylated interferon alpha 2a; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Ribavirin; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Pegylated interferon alpha 2 b plus ribavirin; Assigned to Arm(s): 2
B: Arm Label: PegIntron 1.5 ug/kg/wk plus REBETOL; Type: EXPERIMENTAL; Interventions: Biological: PegIntron (peginterferon alfa-2b; SCH 54031), Drug: REBETOL (ribavirin; SCH 18908) | Arm Label: PegIntron 1.0 ug/kg/wk plus REBETOL; Type: EXPERIMENTAL; Interventions: Biological: PegIntron (peginterferon alfa-2b; SCH 54031), Drug: REBETOL (ribavirin; SCH 18908) | Arm Label: PEGASYS 180 ug/wk Plus COPEGUS; Type: ACTIVE_COMPARATOR; Interventions: Biological: PEGASYS (peginterferon alfa-2a), Drug: COPEGUS (ribavirin) | Intervention Type: BIOLOGICAL; Name: PegIntron (peginterferon alfa-2b; SCH 54031); Assigned to Arm(s): PegIntron 1.5 ug/kg/wk plus REBETOL | Intervention Type: BIOLOGICAL; Name: PegIntron (peginterferon alfa-2b; SCH 54031); Assigned to Arm(s): PegIntron 1.0 ug/kg/wk plus REBETOL | Intervention Type: DRUG; Name: REBETOL (ribavirin; SCH 18908); Assigned to Arm(s): PegIntron 1.0 ug/kg/wk plus REBETOL, PegIntron 1.5 ug/kg/wk plus REBETOL | Intervention Type: BIOLOGICAL; Name: PEGASYS (peginterferon alfa-2a); Assigned to Arm(s): PEGASYS 180 ug/wk Plus COPEGUS | Intervention Type: DRUG; Name: COPEGUS (ribavirin); Assigned to Arm(s): PEGASYS 180 ug/wk Plus COPEGUS
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Peginterferon alfa-2a + Ribavirin, Drug: Peginterferon alfa-2a | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Peginterferon alfa-2a + Ribavirin | Intervention Type: DRUG; Name: Peginterferon alfa-2a + Ribavirin; Assigned to Arm(s): 1, 2 | Intervention Type: DRUG; Name: Peginterferon alfa-2a; Assigned to Arm(s): 1
D: Arm Label: Peginterferon Alfa-2a + Ribavirin; Type: EXPERIMENTAL; Interventions: Drug: Ribavirin, Drug: Peginterferon alfa-2a [Pegasys] | Arm Label: Peginterferon Alfa-2b + Ribavirin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Peginterferon alfa-2b (PEG-Intron), Drug: Ribavirin | Intervention Type: DRUG; Name: Ribavirin; Assigned to Arm(s): Peginterferon Alfa-2a + Ribavirin | Intervention Type: DRUG; Name: Peginterferon alfa-2b (PEG-Intron); Assigned to Arm(s): Peginterferon Alfa-2b + Ribavirin | Intervention Type: DRUG; Name: Ribavirin; Assigned to Arm(s): Peginterferon Alfa-2b + Ribavirin | Intervention Type: DRUG; Name: Peginterferon alfa-2a [Pegasys]; Assigned to Arm(s): Peginterferon Alfa-2a + Ribavirin

Answer: D